Dashboard
Analysis
Charting
Screener
Resources
Settings
NYSE-S
Jan '20
Jan '21
Jan '22
Jan '23
Jan '24
Jan '25
Trailing Valuation
Stock Price
17.9
18.3
18.5
24
25.8
22.9
Total Shares Outstanding
339.8
332.1
331.1
325.6
320.1
315.9
Market Cap
6,064.6
6,091.3
6,124.8
7,797.6
8,255.7
7,234.7
Total Enterprise Value (TEV)
5,414.7
5,280.5
5,357.9
7,075.7
7,615.6
6,546.7
Buyback Yield
-0.4%
-0.6%
-0.7%
Shareholder Yield
P/S
6.3
6.7
7.1
9.5
10.7
10
P/Gross Profit
8.5
9
12.8
14.5
13.6
P/E
-14.3
-13.9
-14
-26
-27.4
-24.6
Earnings Yield
-7%
-7.2%
-7.1%
-3.8%
-3.6%
-4.1%
P/OCF
88.1
149.8
139.2
231.2
266.8
455.3
P/FCF
89
153
142.8
244.7
283.8
530.3
FCF Yield
1.1%
0.7%
0.4%
0.2%
P/B
3.9
4
4.7
5
4.4
EV/Sales
5.7
5.8
6.2
8.6
9.9
EV/Gross Profit
7.6
7.8
8.3
11.6
13.4
12.3
EV/EBITDA
-24
-32.2
-33.7
-29.3
EV/EBIT
-16.8
-15.6
-15.9
-21.5
-23.1
-20.3
EV/OCF
78.7
129.9
121.8
209.8
246.1
412
EV/FCF
79.5
132.6
125
222
261.8
479.9
Margins
Gross Profit Margin
74.7%
75%
74.8%
74.3%
73.7%
73.3%
Operating Margin
-33.7%
-37.2%
-38.9%
-40.1%
-42.9%
-44.6%
EBITDA Margin
-20.6%
-24.2%
-25.8%
-26.8%
-29.3%
-30.9%
Net Profit Margin
-43%
-47.3%
-49.4%
-35.1%
-37.6%
Effective Tax Rate
-49%
-48.3%
-48.2%
-2.4%
-2.6%
Pre-Tax Profit Margin
-28.9%
-31.9%
-33.3%
-34.3%
-36.7%
-37.9%
Free Cash Flow Margin
7.1%
4.4%
5%
3.9%
3.8%
1.9%
OCF / Sales
7.2%
4.5%
5.1%
4.1%
4%
2.2%
OCF / Net Income
-16.7%
-9.5%
-10.3%
-11.7%
-10.7%
-5.6%
FCF / OCF
99%
98%
97.5%
94.5%
94%
85.8%
FCF / Net Income
-16.6%
-9.3%
-10.1%
-11%
-10%
-4.8%
FCF / EBITDA
-34.5%
-18.1%
-19.2%
-14.5%
-12.9%
-6.1%
Capital Efficiency
Return on Invested Capital
-25.2%
-28.1%
-27.4%
-18.5%
-20.9%
-20.8%
Return on Assets
-20%
-21.2%
-21%
-14.1%
-14.8%
-14.6%
Return on Equity
-27.3%
-17.4%
-18%
-17.5%
Return on Total Capital
-4,753.7%
-4,965.9%
-4,945.1%
-3,346.9%
-1,572.2%
-1,534.6%
Return on Capital Employed
-18.9%
-19.1%
-18.7%
Return on Tangible Assets
-26.4%
-26%
-18.4%
Receivables Turnover
5.3
5.4
4.1
5.2
Days Sales Outstanding
69.4
69.2
67.5
70.7
72.9
Payables Turnover
25
23.4
13.9
23.6
17.2
18.8
Days Payables Outstanding
14.6
15.6
26.2
15.4
21.2
19.4
Cash Conversion Cycle
54.8
53.6
41.3
73.6
49.5
53.4
Asset Turnover
0.4
0.3
Fixed Asset Turnover
11.1
10.8
10.5
10.2
9.8
Operating Cycle
CapEx to OCF
0
0.1
CapEx to Revenue
CapEx to Depreciation
Financial Health
Total Debt
—
20.1
Net Debt
-649.8
-810.8
-766.9
-721.9
-640.2
-688
Current Ratio
1.5
1.8
1.7
1.6
Quick Ratio
1.4
Cash Ratio
1
1.3
1.2
1.1
Debt Ratio
Assets to Equity
Cash Flow to Debt Ratio
0.8
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
74.9
250
193.2
332.3
263.5
307.8
Goodwill / Assets
Debt / Equity
Total Debt / Capitalization
Long Term Debt / Capitalization
0.7
Long-Term Debt / Equity
Net Debt / EBITDA
3.3
3.7
3.4
2.8
3.1
EBIT / Interest Expense
-1,926.1
EBITDA / Interest Expense
-1,286.3
(EBITDA - Capex) / Interest Expense
-1,297.2
Per Share
Revenue per Share
2.9
2.7
2.6
2.5
2.4
Basic EPS
-1.3
-0.9
Diluted EPS
Book Value per Share
4.6
4.8
Tangible Book Value per Share
3
Cash per Share
2
2.3
2.1
Operating Cash Flow per Share
0.2
Free Cash Flow per Share
CapEx per Share
Weighted Avg. Shares Outstanding
328.3
324.3
319.8
314.8
310.1
305
Weighted Avg. Shares Outstanding Diluted
Common Size
R&D to Revenue
32.3%
32.7%
32.5%
31.9%
SG&A to Revenue
78.5%
80.6%
81.9%
84%
85.7%
Stock-based Comp to Revenue
30.6%
31.6%
32.1%
32.6%
32%
